(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-2,6,10,15,19-Pentamethyl-21-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8,10,12,14,16,18,20-heneicosadecaenoic acid → Lactucaxanthin

HRID 2223477

Reaction equation

HRID 2223477 reaction equation
[CH3:1]/[C:2](/[CH:27]=[CH:28]/[CH:29]=[C:30](/[CH:32]=[C:33]=[C:34]1[C:39]([CH3:41])([CH3:40])[CH2:38][C@H:37]([OH:42])[CH2:36][C@:35]1(O)[CH3:43])\[CH3:31])=[CH:3]\[CH:4]=[CH:5]\[CH:6]=[C:7](\[CH:9]=[CH:10]\[CH:11]=[C:12](/[CH:14]1O[C@:17]2([CH3:26])[CH2:19][C@@H:20]([OH:25])[CH2:21][C:22]([CH3:24])([CH3:23])[C:16]2=[CH:15]1)\[CH3:13])/[CH3:8].CC1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C=C\C=C(\C=C\C1C(C)(C)CCCC=1C)/C)/C.C/C(/C=C/C=C(/C=C/[C@]12C(C)(C)C[C@H](O)C[C@@]1(C)O2)\C)=C\C=C\C=C(\C=C\C=C(\C=C=C1C(C)(C)C[C@H](O)C[C@]1(O)C)/C)/C.CC1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(/C=C/C=C(/C=C/C=C(/C(O)=O)\C)\C)\C.CC1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(/C=C/C=C(/C=C/C=C(/C(OC)=O)\C)\C)\C.CC(C)=CCC/C(/C)=C/CC/C(/C)=C/C=C/C(/C)=C/C=C/C=C(/C=C/C=C(/C=C/C=C(/CCC=C(C)C)\C)\C)\C.CC1[C@H](/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(/C=C/C=C(/C=C/C=C(/CCC=C(C)C)\C)\C)\C)C(C)(C)C(C/C=C(/CO)\C)CC=1.C/C(/C=C/C=C(\C)/C=C/C(O)=O)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C(O)=O.CC1C[C@@H](O)[C@H](O)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1C(C)(C)[C@@H](O)[C@H](O)CC=1C>>[CH3:26][C:17]1[C@H:16](/[CH:15]=[CH:14]/[C:12](/[CH3:13])=[CH:11]/[CH:10]=[CH:9]/[C:7](/[CH3:8])=[CH:6]/[CH:5]=[CH:4]/[CH:3]=[C:2](\[CH3:1])/[CH:27]=[CH:28]/[CH:29]=[C:30](\[CH3:31])/[CH:32]=[CH:33]/[C@H:34]2[C:35]([CH3:43])=[CH:36][C@H:37]([OH:42])[CH2:38][C:39]2([CH3:41])[CH3:40])[C:22]([CH3:24])([CH3:23])[CH2:21][C@@H:20]([OH:25])[CH:19]=1

Participants

10

Reactant 9

HCID 637039(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-2,6,10,15,19-Pentamethyl-21-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8,10,12,14,16,18,20-heneicosadecaenoic acidHCID 5280789NeurosporeneHCID 5281247all-trans-NeoxanthinHCID 5281249NorbixinHCID 5380055Neurosporaxanthin methyl esterHCID 10256668(13Z)-beta-CaroteneHCID 16061239NostoxanthinHCID 101526842trans-(1R,3S)-6-[(3E,5E,7E,9E,11E,13E,15Z)-16-[(6S,7aR)-6-hydroxy-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-2-yl]-3,7,12-trimethylheptadeca-1,3,5,7,9,11,13,15-octaenylidene]-1,5,5-trimethylcyclohexane-1,3-diolHCID 102154122(E)-4-[(5S)-5-[(1E,3E,5E,7E,9E,11E,13E,15E,17E,19E)-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,23-undecaenyl]-4,6,6-trimethylcyclohex-3-en-1-yl]-2-methylbut-2-en-1-ol

Product 1

HCID 5281242Lactucaxanthin

Procedure

Neocarotene; Neochrome; Neo-β-carotene B; Neo-β-cryptoxanthin A; Neoxanthin; Neoxanthin 3-acetate; Neurosporaxanthin; Neurosporaxanthin methyl ester; Neurosporene; Nonaprenoxanthin; 2′-Nor-astaxanthin diester; Norbixin; Nostoxanthin;

Sources & evidence

ORD record
ord-0d167507c1734d989f5fd28b0640071a
Source dataset
uspto-grants-2008_05
Patent number
US07375133B2

Linked notes

Loading…